Octave Bioscience expands leadership team

US commercial stage precision-care company Octave Bioscience has announced the appointment of Kirk Stockwood as senior vice president, commercial. Mr Stockwood will spearhead Octave’s commercial strategy as the company scales operations and expands the reach of its precision neurology platform.

Mr Stockwood brings over 20 years of leadership experience in specialty diagnostics and tools, with a proven track record of commercial scaling within public and private companies. Most recently as VP of sales at Quanterix, he led a global team focused on neurology and immunology that delivered 12 consecutive quarters of double-digit revenue growth. Prior to that, Mr Stockwood played a pivotal role in the massive commercial expansion of Natera (Nasdaq: NTRA), where he scaled the sales organization and led the launch of the flagship Panorama NIPT assay. His background also includes senior commercial leadership roles at 10x Genomics, Veritas Genetics, and Color Genomics, where he drove strategic product launches and market expansion efforts.